# Subpart 10—fees relating to over-the-counter drugs

Subpart 10—fees relating to over-the-counter drugs is a U.S. Code division of [Part C—Fees](https://ontology.bommaritollc.com/id/01a0f06c-cba2-746e-bd82-4db016b32247); in force.

IRI: <https://ontology.bommaritollc.com/id/01a0f06c-cbac-77fa-ab06-64da3252fe48>

Within: [Title 21—Food and Drugs](https://ontology.bommaritollc.com/id/01a0f06c-cb65-7672-8fda-c39517ff08c0) › [Chapter 9—Federal Food, Drug, and Cosmetic Act](https://ontology.bommaritollc.com/id/01a0f06c-cb91-72e0-858b-060e8c845f23) › [Subchapter VII—General Authority](https://ontology.bommaritollc.com/id/01a0f06c-cba0-7476-aff5-2e37cf9afce5) › [Part C—Fees](https://ontology.bommaritollc.com/id/01a0f06c-cba2-746e-bd82-4db016b32247)

Type: [schema:Legislation](https://schema.org/Legislation)

- `adms:identifier`: [usc-division 21 U.S.C. Chapter 9, Subchapter VII, Part C, Subpart 10](https://ontology.bommaritollc.com/id/01a0f06c-cbac-77fa-ab06-64e41a33dac4)
- `prov:wasDerivedFrom`:
  - [evidence from https://www.govinfo.gov/app/details/USCODE-2024-title21](https://ontology.bommaritollc.com/id/01a0f06c-cbac-77fa-ab06-64d9ccb6c44f)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f06c-d071-73fb-8a48-b46f08b8f02b)
- `schema:isPartOf`: [Part C—Fees](https://ontology.bommaritollc.com/id/01a0f06c-cba2-746e-bd82-4db016b32247)
- `schema:legislationIdentifier`: 21 U.S.C. Chapter 9, Subchapter VII, Part C, Subpart 10
- `schema:legislationJurisdiction`: [United States](https://ontology.bommaritollc.com/id/01a0ed8e-f797-7004-b7f5-bec2695977c0)
- `schema:legislationLegalForce`: [schema:InForce](https://schema.org/InForce)
- `schema:legislationType`: [U.S. Code division](https://ontology.bommaritollc.com/vocab/leg/uscDivision)
- `skos:prefLabel`: Subpart 10—fees relating to over-the-counter drugs

## Elsewhere

- [Source](https://www.govinfo.gov/app/details/USCODE-2024-title21) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/) (www.govinfo.gov)

## Pointing here

- Parts (3; `schema:isPartOf`):
  - [21 U.S.C. 379j-71 Definitions](https://ontology.bommaritollc.com/id/01a0f06c-cdb5-70f4-9a83-cd54cfae78b0)
  - [21 U.S.C. 379j-72 Authority to assess and use OTC monograph fees](https://ontology.bommaritollc.com/id/01a0f06c-cde3-7321-9d83-cdaa72dac705)
  - [21 U.S.C. 379j-73 Reauthorization; reporting requirements](https://ontology.bommaritollc.com/id/01a0f06c-cde6-74c4-98ae-47430686e6b6)

---
Also as: [Turtle](https://ontology.bommaritollc.com/id/01a0f06c-cbac-77fa-ab06-64da3252fe48.ttl), [JSON-LD](https://ontology.bommaritollc.com/id/01a0f06c-cbac-77fa-ab06-64da3252fe48.jsonld), [N-Triples](https://ontology.bommaritollc.com/id/01a0f06c-cbac-77fa-ab06-64da3252fe48.nt), [HTML](https://ontology.bommaritollc.com/id/01a0f06c-cbac-77fa-ab06-64da3252fe48)
Cite as: Subpart 10—fees relating to over-the-counter drugs. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0f06c-cbac-77fa-ab06-64da3252fe48
Release 0.1.0-rc38, graph hash 05350a11cf9d0c42fba51e92b877115781ab65cb92afcd6b172ff9f8f4abf0bd.
